{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T16:03:09Z","timestamp":1788624189300,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00774-020-01174-2","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:06:58Z","timestamp":1605571618000},"page":"372-384","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Tooth extraction in mice administered zoledronate increases inflammatory cytokine levels and promotes osteonecrosis of the jaw"],"prefix":"10.1007","volume":"39","author":[{"given":"Tomoya","family":"Soma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuiko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tami","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisato","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morio","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Asoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Kawana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taneaki","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"1174_CR1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115\u20131117","journal-title":"J Oral Maxillofac Surg"},{"key":"1174_CR2","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O\u2019Ryan F (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update. J Oral Maxillofac Surg 72:1938\u20131956","journal-title":"J Oral Maxillofac Surg"},{"key":"1174_CR3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1634\/theoncologist.2010-0183","volume":"16","author":"RA Miksad","year":"2011","unstructured":"Miksad RA, Lai KC, Dodson TB, Woo SB, Treister NS, Akinyemi O, Bihrle M, Maytal G, August M, Gazelle GS, Swan JS (2011) Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist 16:121\u2013132","journal-title":"Oncologist"},{"key":"1174_CR4","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1210\/jc.2006-2036","volume":"92","author":"M Khamaisi","year":"2007","unstructured":"Khamaisi M, Regev E, Yarom N, Avni B, Leitersdorf E, Raz I, Elad S (2007) Possible association between diabetes and bisphosphonate-related jaw osteonecrosis. J Clin Endocrinol Metab 92:1172\u20131175","journal-title":"J Clin Endocrinol Metab"},{"key":"1174_CR5","doi-asserted-by":"crossref","first-page":"E1807","DOI":"10.1210\/jc.2013-2434","volume":"98","author":"S Molcho","year":"2013","unstructured":"Molcho S, Peer A, Berg T, Futerman B, Khamaisi M (2013) Diabetes microvascular disease and the risk for bisphosphonate-related osteonecrosis of the jaw: a single center study. J Clin Endocrinol Metab 98:E1807\u20131812","journal-title":"J Clin Endocrinol Metab"},{"key":"1174_CR6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/hed.23260","volume":"36","author":"SA Berti-Couto","year":"2014","unstructured":"Berti-Couto SA, Vasconcelos AC, Iglesias JE, Figueiredo MA, Salum FG, Cherubini K (2014) Diabetes mellitus and corticotherapy as risk factors for alendronate-related osteonecrosis of the jaws: a study in Wistar rats. Head Neck 36:84\u201393","journal-title":"Head Neck"},{"key":"1174_CR7","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1080\/10428194.2017.1300889","volume":"58","author":"E Kastritis","year":"2017","unstructured":"Kastritis E, Melea P, Bagratuni T, Melakopoulos I, Gavriatopoulou M, Roussou M, Migkou M, Eleutherakis-Papaiakovou E, Terpos E, Dimopoulos MA (2017) Genetic factors related with early onset of osteonecrosis of the jaw in patients with multiple myeloma under zoledronic acid therapy. Leuk Lymphoma 58:2304\u20132309","journal-title":"Leuk Lymphoma"},{"key":"1174_CR8","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.mayocp.2013.01.002","volume":"88","author":"TD Rachner","year":"2013","unstructured":"Rachner TD, Platzbecker U, Felsenberg D, Hofbauer LC (2013) Osteonecrosis of the jaw after osteoporosis therapy with denosumab following long-term bisphosphonate therapy. Mayo Clin Proc 88:418\u2013419","journal-title":"Mayo Clin Proc"},{"key":"1174_CR9","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.080205","volume":"23","author":"AO Hoff","year":"2008","unstructured":"Hoff AO, Toth BB, Altundag K, Johnson MM, Warneke CL, Hu M, Nooka A, Sayegh G, Guarneri V, Desrouleaux K, Cui J, Adamus A, Gagel RF, Hortobagyi GN (2008) Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 23:826\u2013836","journal-title":"J Bone Miner Res"},{"key":"1174_CR10","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jcms.2015.03.039","volume":"43","author":"S Otto","year":"2015","unstructured":"Otto S, Troltzsch M, Jambrovic V, Panya S, Probst F, Ristow O, Ehrenfeld M, Pautke C (2015) Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: a trigger for BRONJ development? J Craniomaxillofac Surg 43:847\u2013854","journal-title":"J Craniomaxillofac Surg"},{"key":"1174_CR11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/annonc\/mdn526","volume":"20","author":"CI Ripamonti","year":"2009","unstructured":"Ripamonti CI, Maniezzo M, Campa T, Fagnoni E, Brunelli C, Saibene G, Bareggi C, Ascani L, Cislaghi E (2009) Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. Ann Oncol 20:137\u2013145","journal-title":"Ann Oncol"},{"key":"1174_CR12","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ijom.2014.08.011","volume":"44","author":"O Sakaguchi","year":"2015","unstructured":"Sakaguchi O, Kokuryo S, Tsurushima H, Tanaka J, Habu M, Uehara M, Nishihara T, Tominaga K (2015) Lipopolysaccharide aggravates bisphosphonate-induced osteonecrosis in rats. Int J Oral Maxillofac Surg 44:528\u2013534","journal-title":"Int J Oral Maxillofac Surg"},{"key":"1174_CR13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jcms.2014.12.008","volume":"43","author":"FJ Manzano-Moreno","year":"2015","unstructured":"Manzano-Moreno FJ, Ramos-Torrecillas J, De Luna-Bertos E, Ruiz C, Garcia-Martinez O (2015) High doses of bisphosphonates reduce osteoblast-like cell proliferation by arresting the cell cycle and inducing apoptosis. J Craniomaxillofac Surg 43:396\u2013401","journal-title":"J Craniomaxillofac Surg"},{"key":"1174_CR14","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.11607\/jomi.te61","volume":"29","author":"RE Marx","year":"2014","unstructured":"Marx RE (2014) A decade of bisphosphonate bone complications: what it has taught us about bone physiology. Int J Oral Maxillofac Implants 29:e247\u2013258","journal-title":"Int J Oral Maxillofac Implants"},{"key":"1174_CR15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijom.2015.01.026","volume":"44","author":"R Fliefel","year":"2015","unstructured":"Fliefel R, Troltzsch M, Kuhnisch J, Ehrenfeld M, Otto S (2015) Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. Int J Oral Maxillofac Surg 44:568\u2013585","journal-title":"Int J Oral Maxillofac Surg"},{"key":"1174_CR16","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/jbmr.1894","volume":"28","author":"B Kang","year":"2013","unstructured":"Kang B, Cheong S, Chaichanasakul T, Bezouglaia O, Atti E, Dry SM, Pirih FQ, Aghaloo TL, Tetradis S (2013) Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice. J Bone Miner Res 28:1631\u20131640","journal-title":"J Bone Miner Res"},{"key":"1174_CR17","doi-asserted-by":"crossref","first-page":"17349","DOI":"10.1074\/jbc.M115.652305","volume":"290","author":"S Park","year":"2015","unstructured":"Park S, Kanayama K, Kaur K, Tseng HC, Banankhah S, Quje DT, Sayre JW, Jewett A, Nishimura I (2015) Osteonecrosis of the jaw developed in mice: disease variants regulated by gammadelta t cells in oral mucosal barrier immunity. J Biol Chem 290:17349\u201317366","journal-title":"J Biol Chem"},{"key":"1174_CR18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bone.2016.06.011","volume":"90","author":"A Soundia","year":"2016","unstructured":"Soundia A, Hadaya D, Esfandi N, de Molon RS, Bezouglaia O, Dry SM, Pirih FQ, Aghaloo T, Tetradis S (2016) Osteonecrosis of the jaws (ONJ) in mice after extraction of teeth with periradicular disease. Bone 90:133\u2013141","journal-title":"Bone"},{"key":"1174_CR19","doi-asserted-by":"crossref","first-page":"20602","DOI":"10.1074\/jbc.M116.735795","volume":"291","author":"Y Sun","year":"2016","unstructured":"Sun Y, Kaur K, Kanayama K, Morinaga K, Park S, Hokugo A, Kozlowska A, McBride WH, Li J, Jewett A, Nishimura I (2016) Plasticity of Myeloid Cells during Oral Barrier Wound Healing and the Development of Bisphosphonate-related Osteonecrosis of the Jaw. J Biol Chem 291:20602\u201320616","journal-title":"J Biol Chem"},{"key":"1174_CR20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/jbmr.3292","volume":"33","author":"S Kuroshima","year":"2018","unstructured":"Kuroshima S, Sasaki M, Nakajima K, Tamaki S, Hayano H, Sawase T (2018) Transplantation of noncultured stromal vascular fraction cells of adipose tissue ameliorates osteonecrosis of the jaw-like lesions in mice. J Bone Miner Res 33:154\u2013166","journal-title":"J Bone Miner Res"},{"key":"1174_CR21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2353\/ajpath.2010.090592","volume":"177","author":"Y Bi","year":"2010","unstructured":"Bi Y, Gao Y, Ehirchiou D, Cao C, Kikuiri T, Le A, Shi S, Zhang L (2010) Bisphosphonates cause osteonecrosis of the jaw-like disease in mice. Am J Pathol 177:280\u2013290","journal-title":"Am J Pathol"},{"key":"1174_CR22","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jbmr.37","volume":"25","author":"T Kikuiri","year":"2010","unstructured":"Kikuiri T, Kim I, Yamaza T, Akiyama K, Zhang Q, Li Y, Chen C, Chen W, Wang S, Le AD, Shi S (2010) Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice. J Bone Miner Res 25:1668\u20131679","journal-title":"J Bone Miner Res"},{"key":"1174_CR23","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s00223-012-9649-7","volume":"91","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Wang L, Liu Y, Akiyama K, Chen C, Atsuta I, Zhou T, Duan X, Jin Y, Shi S (2012) Technetium-99 conjugated with methylene diphosphonate ameliorates ovariectomy-induced osteoporotic phenotype without causing osteonecrosis in the jaw. Calcif Tissue Int 91:400\u2013408","journal-title":"Calcif Tissue Int"},{"key":"1174_CR24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jcms.2015.12.010","volume":"44","author":"M Zandi","year":"2016","unstructured":"Zandi M, Dehghan A, Malekzadeh H, Janbaz P, Ghadermazi K, Amini P (2016) Introducing a protocol to create bisphosphonate-related osteonecrosis of the jaw in rat animal model. J Craniomaxillofac Surg 44:271\u2013278","journal-title":"J Craniomaxillofac Surg"},{"key":"1174_CR25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.coms.2015.06.002","volume":"27","author":"MR Allen","year":"2015","unstructured":"Allen MR (2015) Medication-related osteonecrosis of the jaw: basic and translational science updates. Oral Maxillofac Surg Clin North Am 27:497\u2013508","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"1174_CR26","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/jbmr.2097","volume":"29","author":"TL Aghaloo","year":"2014","unstructured":"Aghaloo TL, Cheong S, Bezouglaia O, Kostenuik P, Atti E, Dry SM, Pirih FQ, Tetradis S (2014) RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease. J Bone Miner Res 29:843\u2013854","journal-title":"J Bone Miner Res"},{"key":"1174_CR27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/iep.12007","volume":"94","author":"N Conte Neto","year":"2013","unstructured":"Conte Neto N, Spolidorio LC, Andrade CR, Bastos S, Guimaraes M, Marcantonio E Jr (2013) Experimental development of bisphosphonate-related osteonecrosis of the jaws in rodents. Int J Exp Pathol 94:65\u201373","journal-title":"Int J Exp Pathol"},{"key":"1174_CR28","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jcms.2017.07.002","volume":"45","author":"S Otto","year":"2017","unstructured":"Otto S, Pautke C, Martin Jurado O, Nehrbass D, Stoddart MJ, Ehrenfeld M, Zeiter S (2017) Further development of the MRONJ minipig large animal model. J Craniomaxillofac Surg 45:1503\u20131514","journal-title":"J Craniomaxillofac Surg"},{"key":"1174_CR29","doi-asserted-by":"crossref","first-page":"46322","DOI":"10.1038\/srep46322","volume":"7","author":"M Morita","year":"2017","unstructured":"Morita M, Iwasaki R, Sato Y, Kobayashi T, Watanabe R, Oike T, Nakamura S, Keneko Y, Miyamoto K, Ishihara K, Iwakura Y, Ishii K, Matsumoto M, Nakamura M, Kawana H, Nakagawa T, Miyamoto T (2017) Elevation of pro-inflammatory cytokine levels following anti-resorptive drug treatment is required for osteonecrosis development in infectious osteomyelitis. Sci Rep 7:46322","journal-title":"Sci Rep"},{"key":"1174_CR30","doi-asserted-by":"crossref","first-page":"15783","DOI":"10.1038\/s41598-018-34173-5","volume":"8","author":"T Oike","year":"2018","unstructured":"Oike T, Kanagawa H, Sato Y, Kobayashi T, Nakatsukasa H, Miyamoto K, Nakamura S, Kaneko Y, Kobayashi S, Harato K, Yoshimura A, Iwakura Y, Takeuchi T, Matsumoto M, Nakamura M, Niki Y, Miyamoto T (2018) IL-6, IL-17 and Stat3 are required for auto-inflammatory syndrome development in mouse. Sci Rep 8:15783","journal-title":"Sci Rep"},{"key":"1174_CR31","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1038\/onc.2013.545","volume":"33","author":"T Mori","year":"2014","unstructured":"Mori T, Sato Y, Miyamoto K, Kobayashi T, Shimizu T, Kanagawa H, Katsuyama E, Fujie A, Hao W, Tando T, Iwasaki R, Kawana H, Morioka H, Matsumoto M, Saya H, Toyama Y, Miyamoto T (2014) TNFalpha promotes osteosarcoma progression by maintaining tumor cells in an undifferentiated state. Oncogene 33:4236\u20134241","journal-title":"Oncogene"},{"key":"1174_CR32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41467-020-14285-1","volume":"11","author":"JS Brunner","year":"2020","unstructured":"Brunner JS, Vulliard L, Hofmann M, Kieler M, Lercher A et al (2020) Environmental arginine controls multinuclear giant cell metabolism and formation. Nat Commun 11:431","journal-title":"Nat Commun"},{"key":"1174_CR33","doi-asserted-by":"crossref","first-page":"e0134391","DOI":"10.1371\/journal.pone.0134391","volume":"10","author":"I Gurt","year":"2015","unstructured":"Gurt I, Artsi H, Cohen-Kfir E, Hamdani G, Ben-Shalom G, Feinstein B, El-Haj M, Dresner-Pollak R (2015) The Sirt1 activators SRT2183 and SRT3025 inhibit RANKL-induced osteoclastogenesis in bone marrow-derived macrophages and down-regulate Sirt3 in Sirt1 null cells. PLoS ONE 10:e0134391","journal-title":"PLoS ONE"},{"key":"1174_CR34","doi-asserted-by":"crossref","first-page":"e111845","DOI":"10.1371\/journal.pone.0111845","volume":"9","author":"Y Sato","year":"2014","unstructured":"Sato Y, Miyauchi Y, Yoshida S, Morita M, Kobayashi T, Kanagawa H, Katsuyama E, Fujie A, Hao W, Tando T, Watanabe R, Miyamoto K, Morioka H, Matsumoto M, Toyama Y, Miyamoto T (2014) The vitamin D analogue ED71 but Not 1,25(OH)2D3 targets HIF1\u03b1 protein in osteoclasts. PLoS ONE 9:e111845\u2013e111845","journal-title":"PLoS ONE"},{"key":"1174_CR35","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1074\/jbc.M114.568360","volume":"290","author":"E Katsuyama","year":"2015","unstructured":"Katsuyama E, Miyamoto H, Kobayashi T, Sato Y, Hao W, Kanagawa H, Fujie A, Tando T, Watanabe R, Morita M, Miyamoto K, Niki Y, Morioka H, Matsumoto M, Toyama Y, Miyamoto T (2015) Interleukin-1 receptor-associated kinase-4 (IRAK4) promotes inflammatory osteolysis by activating osteoclasts and inhibiting formation of foreign body giant cells. J Biol Chem 290:716\u2013726","journal-title":"J Biol Chem"},{"key":"1174_CR36","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/jnci\/djh141","volume":"96","author":"F Saad","year":"2004","unstructured":"Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, Chin JL, Vinholes JJ, Goas JA, Zheng M (2004) Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst 96:879\u2013882","journal-title":"J Natl Cancer Inst"},{"key":"1174_CR37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/cncr.11892","volume":"100","author":"LS Rosen","year":"2004","unstructured":"Rosen LS, Gordon DH, Dugan W Jr, Major P, Eisenberg PD, Provencher L, Kaminski M, Simeone J, Seaman J, Chen BL, Coleman RE (2004) Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion. Cancer 100:36\u201343","journal-title":"Cancer"},{"key":"1174_CR38","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.ejca.2012.08.002","volume":"48","author":"A Lipton","year":"2012","unstructured":"Lipton A, Fizazi K, Stopeck AT, Henry DH, Brown JE, Yardley DA, Richardson GE, Siena S, Maroto P, Clemens M, Bilynskyy B, Charu V, Beuzeboc P, Rader M, Viniegra M, Saad F, Ke C, Braun A, Jun S (2012) Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials. Eur J Cancer 48:3082\u20133092","journal-title":"Eur J Cancer"},{"key":"1174_CR39","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","volume":"23","author":"F Saad","year":"2012","unstructured":"Saad F, Brown JE, Van Poznak C, Ibrahim T, Stemmer SM, Stopeck AT, Diel IJ, Takahashi S, Shore N, Henry DH, Barrios CH, Facon T, Senecal F, Fizazi K, Zhou L, Daniels A, Carriere P, Dansey R (2012) Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol 23:1341\u20131347","journal-title":"Ann Oncol"},{"key":"1174_CR40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","volume":"30","author":"AA Khan","year":"2015","unstructured":"Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK et al (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30:3\u201323","journal-title":"J Bone Miner Res"},{"key":"1174_CR41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000151371","volume":"189","author":"MR Allen","year":"2009","unstructured":"Allen MR (2009) Bisphosphonates and osteonecrosis of the jaw: moving from the bedside to the bench. Cells Tissues Organs 189:289\u2013294","journal-title":"Cells Tissues Organs"},{"key":"1174_CR42","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMc1002684","volume":"363","author":"A Cheung","year":"2010","unstructured":"Cheung A, Seeman E (2010) Teriparatide therapy for alendronate-associated osteonecrosis of the jaw. N Engl J Med 363:2473\u20132474","journal-title":"N Engl J Med"},{"key":"1174_CR43","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1007\/s00198-011-1882-9","volume":"23","author":"YD Kwon","year":"2012","unstructured":"Kwon YD, Lee DW, Choi BJ, Lee JW, Kim DY (2012) Short-term teriparatide therapy as an adjunctive modality for bisphosphonate-related osteonecrosis of the jaws. Osteoporos Int 23:2721\u20132725","journal-title":"Osteoporos Int"},{"key":"1174_CR44","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.joms.2006.10.076","volume":"65","author":"RP Harper","year":"2007","unstructured":"Harper RP, Fung E (2007) Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)]. J Oral Maxillofac Surg 65:573\u2013580","journal-title":"J Oral Maxillofac Surg"},{"key":"1174_CR45","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1182\/blood.V98.8.2544","volume":"98","author":"T Miyamoto","year":"2001","unstructured":"Miyamoto T, Ohneda O, Arai F, Iwamoto K, Okada S, Takagi K, Anderson DM, Suda T (2001) Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 98:2544\u20132554","journal-title":"Blood"},{"key":"1174_CR46","doi-asserted-by":"crossref","first-page":"20147","DOI":"10.1074\/jbc.M115.655787","volume":"290","author":"A Kassem","year":"2015","unstructured":"Kassem A, Henning P, Lundberg P, Souza PP, Lindholm C, Lerner UH (2015) Porphyromonas gingivalis stimulates bone resorption by enhancing RANKL (receptor activator of NF-\u03baB ligand) through activation of toll-like receptor 2 in osteoblasts. J Biol Chem 290:20147\u201320158","journal-title":"J Biol Chem"},{"key":"1174_CR47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00774-014-0575-9","volume":"33","author":"H Kanagawa","year":"2015","unstructured":"Kanagawa H, Niki Y, Kobayashi T, Sato Y, Katsuyama E, Fujie A, Hao W, Miyamoto K, Tando T, Watanabe R, Morita M, Morioka H, Matsumoto M, Toyama Y, Miyamoto T (2015) Mycobacterium tuberculosis promotes arthritis development through Toll-like receptor 2. J Bone Miner Metab 33:135\u2013141","journal-title":"J Bone Miner Metab"},{"key":"1174_CR48","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1084\/jem.20101890","volume":"208","author":"K Miyamoto","year":"2011","unstructured":"Miyamoto K, Yoshida S, Kawasumi M, Hashimoto K, Kimura T et al (2011) Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization. J Exp Med 208:2175\u20132181","journal-title":"J Exp Med"},{"key":"1174_CR49","first-page":"04","volume":"10","author":"P Kotian","year":"2016","unstructured":"Kotian P, Boloor A, Sreenivasan S (2016) Study of adverse effect profile of parenteral zoledronic acid in female patients with osteoporosis. J Clin Diagn Res 10:04\u201306","journal-title":"J Clin Diagn Res"},{"key":"1174_CR50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2249.2005.02665.x","volume":"139","author":"RE Hewitt","year":"2005","unstructured":"Hewitt RE, Lissina A, Green AE, Slay ES, Price DA, Sewell AK (2005) The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins. Clin Exp Immunol 139:101\u2013111","journal-title":"Clin Exp Immunol"},{"key":"1174_CR51","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00198-009-0973-3","volume":"21","author":"W Park","year":"2010","unstructured":"Park W, Kim NK, Kim MY, Rhee YM, Kim HJ (2010) Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population: five cases. Osteoporos Int 21:527\u2013533","journal-title":"Osteoporos Int"},{"key":"1174_CR52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.bdj.2009.5","volume":"206","author":"N Malden","year":"2009","unstructured":"Malden N, Beltes C, Lopes V (2009) Dental extractions and bisphosphonates: the assessment, consent and management, a proposed algorithm. Br Dent J 206:93\u201398","journal-title":"Br Dent J"},{"key":"1174_CR53","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjmed.2010.04.033","volume":"123","author":"S Fedele","year":"2010","unstructured":"Fedele S, Porter SR, D\u2019Aiuto F, Aljohani S, Vescovi P, Manfredi M, Arduino PG, Broccoletti R, Musciotto A, Di Fede O, Lazarovici TS, Campisi G, Yarom N (2010) Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series. Am J Med 123:1060\u20131064","journal-title":"Am J Med"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-020-01174-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-020-01174-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-020-01174-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:39:17Z","timestamp":1619656757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-020-01174-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1174"],"URL":"https:\/\/doi.org\/10.1007\/s00774-020-01174-2","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]},"assertion":[{"value":"6 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest with the contents of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Animals were maintained under specific pathogen-free conditions in animal facilities certified by the Keio University Institutional Animal Care and Use Committee, and animal protocols were approved by that committee. All animal studies were performed in accordance with Institutional Guidelines on Animal Experimentation at Keio University of The Keio University Institutional Animal Care and Use Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}